Panacea-UCB alliance takes off with tacrolimus launch in the US
This article was originally published in Scrip
Executive Summary
Panacea Biotec, India's second largest vaccine producer, and UCB group arm, Kremers Urban, have kicked off their 11-product alliance in the US with the launch of Panacea’s immunosuppressant, tacrolimus, there.